737 related articles for article (PubMed ID: 28734074)
1. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
3. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
5. [Atypical profile problem in serological diagnosis of EBV].
Varıcı Balcı FK; Özbek ÖA; Sayıner AA
Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068
[TBL] [Abstract][Full Text] [Related]
6. [Systemic lupus erythematosus and Epstein-Barr virus].
Tazi I; Fehri S; Elghrari K; Ouazzani T; Benchemsi N
East Mediterr Health J; 2009; 15(3):701-8. PubMed ID: 19731786
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
[TBL] [Abstract][Full Text] [Related]
9. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
Appak O; Ozkaratas MH; Sayiner AA
J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
[TBL] [Abstract][Full Text] [Related]
11. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA
Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170
[TBL] [Abstract][Full Text] [Related]
12. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
[TBL] [Abstract][Full Text] [Related]
13. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
Corrales I; Giménez E; Navarro D
Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
[TBL] [Abstract][Full Text] [Related]
16. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
[TBL] [Abstract][Full Text] [Related]
17. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y
Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of the Epstein-Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil.
França SAS; Viana JBGO; Góes HCA; Fonseca RRS; Laurentino RV; Costa IB; Oliveira-Filho AB; Machado LFA
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458425
[TBL] [Abstract][Full Text] [Related]
19. The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections.
Huang Y; Wei C; Zheng K; Zhao D
Virol J; 2013 Feb; 10():55. PubMed ID: 23406068
[TBL] [Abstract][Full Text] [Related]
20. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.
Laurynenka V; Ding L; Kaufman KM; James JA; Harley JB
Front Immunol; 2022; 13():830993. PubMed ID: 35251022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
